glp 1 for alzheimer's Glucagon-like peptide-1 medicines in neurological and psychiatric disorders: Cell Reports Medicine 🧠✨ New research is uncovering

The exact way topiramate causes weight loss is not fully understood, but it is believed to affect several neurotransmitters in the brain

The key principle is patience combined with systematic intervention

Yang L, Chen L, Li D, Xu H, Chen J, Min X, et al

Consulting Your Healthcare Provider: Addressing Concerns and Adjusting Treatment Seeking guidance from your healthcare provider is essential for addressing any concerns and optimizing treatment adjustments to enhance weight loss outcomes while using GLP-1 medication

Orforglipron met ATTAIN-1s primary endpoint by lowering weight by an average of 12.4% (27.3 lbs) vs